What are the major opportunities in the Acquired Immunodeficiency Syndrome (AIDS) market? What are the strategies for the Acquired Immunodeficiency Syndrome (AIDS) market?

For detailed insights on the major opportunities and strategies in the Acquired Immunodeficiency Syndrome (AIDS) market, Read More

How does the Acquired Immunodeficiency Syndrome (AIDS) market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Acquired Immunodeficiency Syndrome (AIDS) market growth and SWOT analysis of the Acquired Immunodeficiency Syndrome (AIDS) industry, Read More

Global Acquired Immunodeficiency Syndrome (AIDS) Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Acquired Immunodeficiency Syndrome (AIDS) Global Market Report 2025

Name: Acquired Immunodeficiency Syndrome (AIDS) Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Human Immunodeficiency Virus 1, Human Immunodeficiency Virus 2), By Drug Type (Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Fusion Inhibitors, CCR5 Anatagonists And Post-Attachment Inhibitors, Protease Inhibitors, Integrase Inhibitors, Pre-Exposure Prophylaxis And Post-Exposure Prophylaxis), By Route Of Administration (Oral, Parenteral), By Application (Hospital Pharmacy, Retail Pharmacy, Other Applications), By Distribution Channel (Offline, Online) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Acquired Immunodeficiency Syndrome (AIDS) Market Overview

• Acquired Immunodeficiency Syndrome (AIDS) market size has reached to $32.09 billion in 2024

• Expected to grow to $41.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%

• Growth Driver: Increasing HIV Infections Driving Demand For Diagnosis Treatment And Prevention Strategies

• Market Trend: Innovative Long-Acting Injectable Therapies Revolutionizing HIV Treatment for Improved Adherence

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Acquired Immunodeficiency Syndrome (AIDS) Market?

Acquired immunodeficiency syndrome (AIDS) is a chronic, life-threatening condition caused by the human immunodeficiency virus (HIV), which progressively weakens the immune system by destroying CD4 T cells, leaving the body vulnerable to opportunistic infections, severe illnesses, and certain cancers in the absence of effective antiretroviral treatment. It is managed by a combination of antiretroviral therapy (ART), regular monitoring of immune function, prevention of opportunistic infections, and comprehensive healthcare support to improve patient outcomes and quality of life.

The main types of acquired immunodeficiency syndrome (AIDS) are human immunodeficiency virus 1 and human immunodeficiency virus 2. Human Immunodeficiency Virus 1 (HIV-1) is a retrovirus that primarily targets the immune system by infecting CD4+ T cells, leading to progressive immunodeficiency and, if untreated, the development of acquired immunodeficiency syndrome (AIDS). The types of drugs include nucleoside-analog reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, fusion inhibitors, CCR5 antagonists, post-attachment inhibitors, protease inhibitors, integrase inhibitors, and pre-exposure prophylaxis and post-exposure prophylaxis, which are given by route of administration such as oral and parenteral. These are used in applications including hospital pharmacy, retail pharmacy, and others, which are distributed through offline and online channels.

Acquired Immunodeficiency Syndrome (AIDS) Market Size and growth rate 2025 to 2029: Graph

What Is The Acquired Immunodeficiency Syndrome (AIDS) Market Size 2025 And Growth Rate?

The acquired immunodeficiency syndrome (AIDS) market size has grown strongly in recent years. It will grow from $32.09 billion in 2024 to $33.75 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to rising HIV infection rates, increasing government funding for HIV treatment, expansion of global awareness programs, improving diagnostic capabilities, and growing support from non-governmental organizations.

What Is The Acquired Immunodeficiency Syndrome (AIDS) Market Growth Forecast?

The acquired immunodeficiency syndrome (AIDS) market size is expected to see strong growth in the next few years. It will grow to $41.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to growing demand for long-acting injectable therapies, increasing adoption of pre-exposure prophylaxis (PrEP), rising investment in HIV cure research, expansion of telemedicine services for HIV care, a growing focus on personalized medicine, and increasing awareness about early HIV diagnosis. Major trends in the forecast period include a shift towards single-tablet regimens, an increasing preference for injectable and implantable HIV treatments, rising demand for digital health solutions in HIV management, growing interest in functional HIV cure strategies, and the expanding role of artificial intelligence in drug discovery.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. could see heightened challenges in Human Immunodeficiency Virus(HIV) Or Acquired Immunodeficiency Syndrome(AIDS) management as tariffs increase the price of antiretroviral drugs and diagnostic kits sourced from Brazil and France, undermining public health initiatives and patient outcomes. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Acquired Immunodeficiency Syndrome (AIDS) Market Segmented?

1) By Type: Human Immunodeficiency Virus 1, Human Immunodeficiency Virus 2

2) By Drug Type: Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Fusion Inhibitors, CCR5 Anatagonists And Post-Attachment Inhibitors, Protease Inhibitors, Integrase Inhibitors, Pre-Exposure Prophylaxis And Post-Exposure Prophylaxis

3) By Route Of Administration: Oral, Parenteral

4) By Application: Hospital Pharmacy, Retail Pharmacy, Other Applications

5) By Distribution Channel: Offline, Online

Subsegments:

1) By Human Immunodeficiency Virus 1 (HIV-1): Antiretroviral Therapy (ART), Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), HIV-1 Diagnostic Tests, HIV-1 Vaccine Development, HIV-1 Opportunistic Infection Management

2) By Human Immunodeficiency Virus 2 (HIV-2): Antiretroviral Therapy (ART) For HIV-2, HIV-2 Diagnostic Tests, HIV-2 Surveillance And Epidemiology, HIV-2 Vaccine Research, Management Of HIV-2 Co-Infections

What Is Driving The Acquired Immunodeficiency Syndrome (AIDS) Market? Increasing HIV Infections Driving Demand For Diagnosis Treatment And Prevention Strategies

The increasing rates of HIV infections are expected to propel the growth of the acquired immunodeficiency syndrome (AIDS) market going forward. HIV infections refer to the condition caused by the human immunodeficiency virus (HIV), which attacks the immune system, weakening the body's ability to fight off infections and diseases. The increasing rates of HIV infections are due to unprotected sexual intercourse with an infected person, sharing needles or syringes, receiving contaminated blood products, having multiple sexual partners, and a weakened immune system or pre-existing sexually transmitted infections. Acquired immunodeficiency syndrome (AIDS) management helps HIV infection patients by promoting early diagnosis, expanding access to effective antiretroviral therapies, enhancing prevention strategies, strengthening healthcare systems that contribute to better control of the virus's spread. For instance, in November 2024, according to the data published by the European Centre for Disease Prevention and Control (ECDC) Sweden-based European Union agency, a total of 112,883 HIV diagnoses were reported in 2023 across 47 out of 53 countries in the region, with 24,731 cases recorded in the European Union/European Economic Area (EU/EEA). The overall crude rate of HIV diagnoses reached 12.7 per 100,000 population, reflecting a 2.4% increase compared to the 12.4 per 100,000 rates observed in 2022. Therefore, increasing HIV infections is driving the acquired immunodeficiency syndrome (AIDS) industry.

Who Are The Major Players In The Global Acquired Immunodeficiency Syndrome (AIDS) Market?

Major companies operating in the acquired immunodeficiency syndrome (AIDS) market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi SA, Bristol-Myers Squibb Company, Abbott, GSK plc, Takeda Pharmaceuticals, Gilead Sciences, Viatris Inc., Teva Pharmaceuticals, Aurobindo Pharma, Cipla Ltd, Shionogi and Co., Dr. Reddy's Laboratories, Lupin, Hetero Drugs Limited, Glenmark Pharmaceuticals Limited, ViiV Healthcare

What Are The Key Trends Of The Global Acquired Immunodeficiency Syndrome (AIDS) Market? Innovative Long-Acting Injectable Therapies Revolutionizing HIV Treatment for Improved Adherence

Major companies operating in the acquired immunodeficiency syndrome (AIDS) market are focusing on developing innovative therapies such as long-acting injectables, which offer improved patient compliance, reduce the frequency of dosing, and provide a more convenient alternative to daily oral antiretroviral treatments. Long-acting injectables are medications administered via injection that are designed to release their active ingredients slowly over an extended period, allowing for less frequent dosing compared to traditional oral medications. For instance, in January 2025, GSK plc., a UK-based pharmaceutical company, announced the approval from the European Commission for long-acting injectable treatment, Vocabria (cabotegravir) plus Rekambys (rilpivirine). It is approved for use in adolescents aged 12 years and older who are living with HIV. This is administered via intramuscular injection, typically every one or two months, depending on the specific treatment plan. The long-acting nature of the injections may improve adherence rates among adolescents who struggle with daily pill regimens.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Acquired Immunodeficiency Syndrome (AIDS) Market? Gilead Sciences Acquires HTI Therapeutic HIV Vaccine Assets From AELIX Therapeutics To Advance HIV Cure Research

In November 2024, Gilead Sciences Inc., a US-based biopharmaceutical company that develops pharmaceuticals acquired investigational assets related to the HTI therapeutic HIV vaccine of AELIX Therapeutics for an undisclosed amount. With this acquisition, Gilead Sciences aims to strengthen its HIV treatment portfolio by leveraging AELIX Therapeutics' investigational HTI therapeutic HIV vaccine to advance research in functional HIV cures and potentially reduce the need for lifelong antiretroviral therapy. AELIX Therapeutics is a Spain-based company that offers treatment and vaccines for acquired immunodeficiency syndrome (AIDS).

What Is The Regional Outlook For The Global Acquired Immunodeficiency Syndrome (AIDS) Market?

North America was the largest region in the acquired immunodeficiency syndrome (AIDS) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acquired Immunodeficiency Syndrome (AIDS) Market?

The acquired immunodeficiency syndrome (AIDS) market consists of sales of products such as long-acting injectable antiretrovirals, broadly neutralizing antibodies (bNAbs), therapeutic HIV vaccines, latency-reversing agents, capsid inhibitors, attachment inhibitors, maturation inhibitors, and pharmacokinetic enhancers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Acquired Immunodeficiency Syndrome (AIDS) Industry?

The acquired immunodeficiency syndrome (aids) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acquired immunodeficiency syndrome (aids) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Acquired Immunodeficiency Syndrome AIDS Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$33.75 billion
Revenue Forecast In 2034	$41.28 billion
Growth Rate	CAGR of 5.2% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The acquired immunodeficiency syndrome (AIDS) market covered in this report is segmented – 1) By Type: Human Immunodeficiency Virus 1, Human Immunodeficiency Virus 2 2) By Drug Type: Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Fusion Inhibitors, CCR5 Anatagonists And Post-Attachment Inhibitors, Protease Inhibitors, Integrase Inhibitors, Pre-Exposure Prophylaxis And Post-Exposure Prophylaxis 3) By Route Of Administration: Oral, Parenteral 4) By Application: Hospital Pharmacy, Retail Pharmacy, Other Applications 5) By Distribution Channel: Offline, Online Subsegments: 1) By Human Immunodeficiency Virus 1 (HIV- 1): Antiretroviral Therapy (ART), Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), HIV-1 Diagnostic Tests, HIV-1 Vaccine Development, HIV-1 Opportunistic Infection Management 2) By Human Immunodeficiency Virus 2 (HIV- 2): Antiretroviral Therapy (ART) For HIV-2, HIV-2 Diagnostic Tests, HIV-2 Surveillance And Epidemiology, HIV-2 Vaccine Research, Management Of HIV-2 Co-Infections
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi SA, Bristol-Myers Squibb Company, Abbott, GSK plc, Takeda Pharmaceuticals, Gilead Sciences, Viatris Inc., Teva Pharmaceuticals, Aurobindo Pharma, Cipla Ltd, Shionogi and Co., Dr. Reddy's Laboratories, Lupin, Hetero Drugs Limited, Glenmark Pharmaceuticals Limited, ViiV Healthcare
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Acquired Immunodeficiency Syndrome (AIDS) Market Characteristics

3. Acquired Immunodeficiency Syndrome (AIDS) Market Trends And Strategies

4. Acquired Immunodeficiency Syndrome (AIDS) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Acquired Immunodeficiency Syndrome (AIDS) Growth Analysis And Strategic Analysis Framework

5.1. Global Acquired Immunodeficiency Syndrome (AIDS) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Acquired Immunodeficiency Syndrome (AIDS) Market Growth Rate Analysis

5.4. Global Acquired Immunodeficiency Syndrome (AIDS) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Acquired Immunodeficiency Syndrome (AIDS) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Acquired Immunodeficiency Syndrome (AIDS) Total Addressable Market (TAM)

6. Acquired Immunodeficiency Syndrome (AIDS) Market Segmentation

6.1. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Immunodeficiency Virus 1

Human Immunodeficiency Virus 2

6.2. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nucleoside-Analog Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

Fusion Inhibitors

CCR5 Anatagonists and Post-Attachment Inhibitors

Protease Inhibitors

Integrase Inhibitors

Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis

6.3. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

6.4. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Other Applications

6.5. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Offline

Online

6.6. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Sub-Segmentation Of Human Immunodeficiency Virus 1 (HIV-1), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antiretroviral Therapy (ART)

Pre-Exposure Prophylaxis (PrEP)

Post-Exposure Prophylaxis (PEP)

HIV-1 Diagnostic Tests

HIV-1 Vaccine Development

HIV-1 Opportunistic Infection Management

6.7. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Sub-Segmentation Of Human Immunodeficiency Virus 2 (HIV-2), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antiretroviral Therapy (ART) For HIV-2

HIV-2 Diagnostic Tests

HIV-2 Surveillance And Epidemiology

HIV-2 Vaccine Research

Management Of HIV-2 Co-Infections

7. Acquired Immunodeficiency Syndrome (AIDS) Market Regional And Country Analysis

7.1. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Acquired Immunodeficiency Syndrome (AIDS) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acquired Immunodeficiency Syndrome (AIDS) Market

8.1. Asia-Pacific Acquired Immunodeficiency Syndrome (AIDS) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acquired Immunodeficiency Syndrome (AIDS) Market

9.1. China Acquired Immunodeficiency Syndrome (AIDS) Market Overview

9.2. China Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acquired Immunodeficiency Syndrome (AIDS) Market

10.1. India Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acquired Immunodeficiency Syndrome (AIDS) Market

11.1. Japan Acquired Immunodeficiency Syndrome (AIDS) Market Overview

11.2. Japan Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acquired Immunodeficiency Syndrome (AIDS) Market

12.1. Australia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acquired Immunodeficiency Syndrome (AIDS) Market

13.1. Indonesia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acquired Immunodeficiency Syndrome (AIDS) Market

14.1. South Korea Acquired Immunodeficiency Syndrome (AIDS) Market Overview

14.2. South Korea Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acquired Immunodeficiency Syndrome (AIDS) Market

15.1. Western Europe Acquired Immunodeficiency Syndrome (AIDS) Market Overview

15.2. Western Europe Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acquired Immunodeficiency Syndrome (AIDS) Market

16.1. UK Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acquired Immunodeficiency Syndrome (AIDS) Market

17.1. Germany Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acquired Immunodeficiency Syndrome (AIDS) Market

18.1. France Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acquired Immunodeficiency Syndrome (AIDS) Market

19.1. Italy Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acquired Immunodeficiency Syndrome (AIDS) Market

20.1. Spain Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acquired Immunodeficiency Syndrome (AIDS) Market

21.1. Eastern Europe Acquired Immunodeficiency Syndrome (AIDS) Market Overview

21.2. Eastern Europe Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acquired Immunodeficiency Syndrome (AIDS) Market

22.1. Russia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acquired Immunodeficiency Syndrome (AIDS) Market

23.1. North America Acquired Immunodeficiency Syndrome (AIDS) Market Overview

23.2. North America Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acquired Immunodeficiency Syndrome (AIDS) Market

24.1. USA Acquired Immunodeficiency Syndrome (AIDS) Market Overview

24.2. USA Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acquired Immunodeficiency Syndrome (AIDS) Market

25.1. Canada Acquired Immunodeficiency Syndrome (AIDS) Market Overview

25.2. Canada Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acquired Immunodeficiency Syndrome (AIDS) Market

26.1. South America Acquired Immunodeficiency Syndrome (AIDS) Market Overview

26.2. South America Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acquired Immunodeficiency Syndrome (AIDS) Market

27.1. Brazil Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acquired Immunodeficiency Syndrome (AIDS) Market

28.1. Middle East Acquired Immunodeficiency Syndrome (AIDS) Market Overview

28.2. Middle East Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acquired Immunodeficiency Syndrome (AIDS) Market

29.1. Africa Acquired Immunodeficiency Syndrome (AIDS) Market Overview

29.2. Africa Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acquired Immunodeficiency Syndrome (AIDS) Market Competitive Landscape And Company Profiles

30.1. Acquired Immunodeficiency Syndrome (AIDS) Market Competitive Landscape

30.2. Acquired Immunodeficiency Syndrome (AIDS) Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Acquired Immunodeficiency Syndrome (AIDS) Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company

31.2. Abbott

31.3. GSK plc

31.4. Takeda Pharmaceuticals

31.5. Gilead Sciences

31.6. Viatris Inc.

31.7. Teva Pharmaceuticals

31.8. Aurobindo Pharma

31.9. Cipla Ltd

31.10. Shionogi and Co.

31.11. Dr. Reddy's Laboratories

31.12. Lupin

31.13. Hetero Drugs Limited

31.14. Glenmark Pharmaceuticals Limited

31.15. ViiV Healthcare

32. Global Acquired Immunodeficiency Syndrome (AIDS) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acquired Immunodeficiency Syndrome (AIDS) Market

34. Recent Developments In The Acquired Immunodeficiency Syndrome (AIDS) Market

35. Acquired Immunodeficiency Syndrome (AIDS) Market High Potential Countries, Segments and Strategies

35.1 Acquired Immunodeficiency Syndrome (AIDS) Market In 2029 - Countries Offering Most New Opportunities

35.2 Acquired Immunodeficiency Syndrome (AIDS) Market In 2029 - Segments Offering Most New Opportunities

35.3 Acquired Immunodeficiency Syndrome (AIDS) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Sub-Segmentation Of Human Immunodeficiency Virus 1 (HIV-1), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Sub-Segmentation Of Human Immunodeficiency Virus 2 (HIV-2), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Johnson and Johnson Financial Performance

Table 80: F. Hoffmann-La Roche Ltd Financial Performance

Table 81: Merck & Co. Inc. Financial Performance

Table 82: Sanofi SA Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Sub-Segmentation Of Human Immunodeficiency Virus 1 (HIV-1), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Sub-Segmentation Of Human Immunodeficiency Virus 2 (HIV-2), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Acquired Immunodeficiency Syndrome (AIDS) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Acquired Immunodeficiency Syndrome (AIDS) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Johnson and Johnson Financial Performance

Figure 80: F. Hoffmann-La Roche Ltd Financial Performance

Figure 81: Merck & Co. Inc. Financial Performance

Figure 82: Sanofi SA Financial Performance

Intestinal Fistula Treatment Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Invasive Aspergillosis Therapeutics : Market Forecast, Transformation, and Long-Term Trajectories

Iron Deficiency Anemia Growth Trajectory: Key Forecasts and Strategic Insights

Lewy Body Dementia Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Acne Drugs Global Market Report 2025 – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics), By End User (Hos...

Walking Aids Global Market Report 2025 – By Product Type (Crutches, Canes, Walkers, Rollators, Other Products), By Technology (Automated, Manual), By End-User (Hospitals And Clinics, Home Care Settings, Other End Users) ...

Immunoassay Global Market Report 2025 – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Monitoring, O...

Sleeping Aids Global Market Report 2025 – By Product( Mattresses And Pillows, Sleep Laboratories, Medications, Prescription-based Drugs, OTC Drugs, Herbal Drugs, Sleep Apnea Devices), By Indication( Insomnia, Sleep Depri...

Syphilis Immunoassay Diagnostics Global Market Report 2025 – By Product (Analyzers, Reagents, Kits, Other Products), By Technology (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other T...

Immunohematology Global Market Report 2025 – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)), By Di...

Immunodiagnostics Global Market Report 2025 – By Product (Reagents And Consumables, Instruments, Software And Services ), By Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immun...

Frequently Asked Questions

What is the definition of the Acquired Immunodeficiency Syndrome (AIDS) market?

How will the Acquired Immunodeficiency Syndrome (AIDS) market drivers and restraints affect the market dynamics? What forces will shape the Acquired Immunodeficiency Syndrome (AIDS) industry going forward?

The market major growth driver - Increasing HIV Infections Driving Demand For Diagnosis Treatment And Prevention Strategies. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Acquired Immunodeficiency Syndrome (AIDS) market?

The acquired immunodeficiency syndrome (aids) market size has grown strongly in recent years. It will grow from $32.09 billion in 2024 to $33.75 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to rising HIV infection rates, increasing government funding for HIV treatment, expansion of global awareness programs, improving diagnostic capabilities, and growing support from non-governmental organizations. The acquired immunodeficiency syndrome (aids) market size is expected to see strong growth in the next few years. It will grow to " $41.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to growing demand for long-acting injectable therapies, increasing adoption of pre-exposure prophylaxis (PrEP), rising investment in HIV cure research, expansion of telemedicine services for HIV care, a growing focus on personalized medicine, and increasing awareness about early HIV diagnosis. Major trends in the forecast period include a shift towards single-tablet regimens, an increasing preference for injectable and implantable HIV treatments, rising demand for digital health solutions in HIV management, growing interest in functional HIV cure strategies, and the expanding role of artificial intelligence in drug discovery. For further insights on this market, request a sample here

How is the Acquired Immunodeficiency Syndrome (AIDS) market segmented?

The acquired immunodeficiency syndrome (aids)market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus 1; Human Immunodeficiency Virus 2
2) By Drug Type: Nucleoside-Analog Reverse Transcriptase Inhibitors; Non-Nucleoside Reverse Transcriptase Inhibitors; Fusion Inhibitors; CCR5 Anatagonists And Post-Attachment Inhibitors; Protease Inhibitors; Integrase Inhibitors; Pre-Exposure Prophylaxis And Post-Exposure Prophylaxis
3) By Route Of Administration: Oral; Parenteral
4) By Application: Hospital Pharmacy; Retail Pharmacy; Other Applications
5) By Distribution Channel: Offline; Online Subsegments:
1) By Human Immunodeficiency Virus 1 (HIV-1): Antiretroviral Therapy (ART); Pre-Exposure Prophylaxis (PrEP); Post-Exposure Prophylaxis (PEP); HIV-1 Diagnostic Tests; HIV-1 Vaccine Development; HIV-1 Opportunistic Infection Management
2) By Human Immunodeficiency Virus 2 (HIV-2): Antiretroviral Therapy (ART) For HIV-2; HIV-2 Diagnostic Tests; HIV-2 Surveillance And Epidemiology; HIV-2 Vaccine Research; Management Of HIV-2 Co-Infections For further insights on this market, request a sample here

Which region has the largest share of the Acquired Immunodeficiency Syndrome (AIDS) market? What are the other regions covered in the report?

North America was the largest region in the acquired immunodeficiency syndrome (AIDS) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acquired immunodeficiency syndrome (AIDS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Acquired Immunodeficiency Syndrome (AIDS) market?

What are the key trends in the Acquired Immunodeficiency Syndrome (AIDS) market?

Major trends in this market include Innovative Long-Acting Injectable Therapies Revolutionizing HIV Treatment for Improved Adherence. For further insights on this market, request a sample here.